Zoledronic Acid Monohydrate
≥98%(HPLC)
- Product Code: 246570
Alias:
Related CAS:118072-93-8
CAS:
165800-06-6
| Molecular Weight: | 272.09 g./mol | Molecular Formula: | C₅H₁₀N₂O₇P₂·H₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08448695 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8℃, dry, sealed |
Product Description:
Used primarily in the treatment of osteoporosis, Paget's disease of bone, and bone metastases, this compound helps reduce bone resorption by inhibiting osteoclast activity. It is effective in increasing bone mineral density, thereby lowering the risk of fractures in postmenopausal women and men with osteoporosis. In oncology, it prevents skeletal-related events in patients with cancers that have spread to bone, such as multiple myeloma and advanced solid tumors. Administered intravenously, it provides a potent option for managing hypercalcemia of malignancy by lowering elevated calcium levels in blood. Its strong affinity for bone tissue allows for infrequent dosing, making it suitable for long-term management in chronic conditions.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 G | 10-20 days | ฿460.00 |
+
-
|
| 1.000 G | 10-20 days | ฿1,450.00 |
+
-
|
| 5.000 G | 10-20 days | ฿5,430.00 |
+
-
|
| 25.000 G | 10-20 days | ฿20,500.00 |
+
-
|
Zoledronic Acid Monohydrate
Used primarily in the treatment of osteoporosis, Paget's disease of bone, and bone metastases, this compound helps reduce bone resorption by inhibiting osteoclast activity. It is effective in increasing bone mineral density, thereby lowering the risk of fractures in postmenopausal women and men with osteoporosis. In oncology, it prevents skeletal-related events in patients with cancers that have spread to bone, such as multiple myeloma and advanced solid tumors. Administered intravenously, it provides a potent option for managing hypercalcemia of malignancy by lowering elevated calcium levels in blood. Its strong affinity for bone tissue allows for infrequent dosing, making it suitable for long-term management in chronic conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :